Scientific Survey
Primary prevention with statins involves the use of these medications in individuals who have not yet experienced a cardiovascular event but have risk factors that predispose them to future cardiovascular disease. The primary goal of statin therapy in primary prevention is to reduce the incidence of heart attacks, strokes, and other cardiovascular events. Additionally, statins have been shown to have anti-inflammatory and plaque-stabilizing effects, further contributing to their cardiovascular protective benefits. While statins have proven benefits in reducing cardiovascular risk, it is important to consider individual patient characteristics, preferences, and potential contraindications when prescribing statins for primary prevention. Shared decision-making between healthcare professionals and patients plays a crucial role in optimizing the benefits of statin therapy while considering potential risks. The survey aims to gather opinions and preferences regarding the diagnosis, intervention planning, treatment, monitoring, and potential side effects of statin therapy for primary prevention in patients with cardiovascular risk factors.
Survey objectives:
1. Identify factors considered when prescribing statins for primary prevention in patients with cardiovascular risk factors.
2. Examine the approach to statin therapy in elderly patients.
3. Compare the perceived safety of different statins in terms of renal function.
4. Assess the consideration of statin for primary prevention in very elderly patients (>85 years) based on the NICE guideline.